NANOTECHNOLOGY IN MEDICINE СЕМ -ТЕСН Apparatus – An ... · And like homeopathy, BRR mode...

1

NANOTECHNOLOGY IN MEDICINE

СЕМ®-ТЕСН Apparatus – An Effective Supplement to Traditional Thera-pies:

• Whenthereisariskofpolypharmacyinapatientwithseveralconditions.• Forpatientswithchronicconditions.• Whenapatientisexperiencingcomplicationsandsideeffectsfrompharmacological

treatment.• Whentraditionaltreatmentmethodsdonotyieldeffectiveresults.• Forpatientswithdrugresistanceorintolerance.• Whentherearecontraindicationsagainstothertreatmentmethods.

Advantages of using the СЕМ®-ТЕСН Apparatus:

1. Severalmethodsfortreatingawiderangeofdiseases:• EHFtherapy—extremelyhighfrequencyelectromagneticradiationinsingle-frequen-

cymodeorusingselectednoise-likemode;• IRtherapy—infraredradiation;• BRRtherapy—usingbackgroundresonanceradiation.2. Compact,withindependentpowersupply.3. Correspondingtophysiotherapeuticmethodswhichareconnectedwithuselowinten-

sivesourcesofelectromagneticradiation.4. Complementsothertreatmentmethods.

СЕМ®-therapy — therapy with the СЕМ®-ТЕСН apparatus uses EHF therapy followed by treatment in BRR mode. СЕМ®-therapy:

• Reducesanytypeofpain,reducesinflammationatpathologicalsites.• Cutsthedurationofstandardtreatmentforawidearrayofdiseases.• Expandsoptionsforout-patientandat-homerehabilitation.• Offerstoolsforprimaryandsecondaryprevention.• Increasetheeffectivenessofpharmacologicaltherapywhilereducingandinsomecases

eveneliminatingdosages.ClinicalresearchesconfirmgoodshippingEHF-therapies,absenceofcomplicationsand

by-effects,includingatlongsupervisionoverthetreatedpatientsuptotwoyearsaftertreat-ment.

2

NANOTECHNOLOGY IN MEDICINEExtremely high frequencies (EHF) are in therangeof30—300GHz(withwave-

lengthsof10-1mm).EHFcausesfrequencyresonanceinbiologicalorganisms,andtherapeuticefficacyisobservedatradiationlevelsmuchlowerthanthosefoundinoth-erranges.Thiscanbeexplainedbyalackofadaptationtothisspecifictypeofcosmic

radiation, which is trapped by the atmosphere, as well as by the signal’s close resemblancetothebody’sownelectromagneticwaves.

What sets the СЕМ®-ТЕСН apparatus apartfromotherEHFtherapiesisitsoptionofus-ingBRRmode,whichoperatesaccording to thehomeopathicprincipleof likecuring like.Andlikehomeopathy,BRRmodeisnon-intensive.

Background resonance radiation therapy (BRR) isbasedontheuseofmemorymaterialsthatcreateaspectralcopyoftheradiationemittedbythecellsoflivingorganismsintheEHFrangeandcauseitsautomaticretransmission(Gunndiode).Byinfluencingthefrequencyresonancesofcellstructures,pathologicalprocessescanbeweakenedorblockedentirely,atthesametimeamplifyingphysiologicaloscillationsandrestoringdynamicequilibriuminthepatient’sbody.

Whenappliedtohumanskin,EHFradiationpenetratestoadepthof300—500microns,meaningthat it isalmostentirelyabsorbedbytheepidermisandupperlayersofthedermis.

Withitsdirecteffectstargetedatnervereceptors,thecapillarybed,skindepositoriesofleuko-cytesandcellsofthediffuseneuro-endocrinesystem,the therapeutic action of EHF therapy is directed at:

• thenervoussystem;• theimmunesystemandphagocytes;• bloodaggregatestateregulators(coagulatoryandanti-coagulatorymechanisms);• humoralregulation.SoEHFtherapyiseffectiveintreatingawidearrayofdiseases.

СЕМ®— Controlled Energy Material Technology

3

NANOTECHNOLOGY IN MEDICINE

Methods for using the СЕМ®-ТЕСН apparatus:

1) EHFandIRradiationcanbeappliedtoapathologicalsite,reflexogeniczonesand/orbioactivepointsonthebodyusinginterchangeableemitterswithvariousmodu-latingfrequenciesandradiationspectrum(theapparatusisprogrammedtoworkoneachzoneorpointfor10minutes);

2) BRRmode:Whentheemitterisappliedtothepathologicalsite,itsdipole-activemodeisadjustedoverthecourseofoneminute,afterwhichitswitchestoautomaticretransmissionatthesamezone(atthispointtheemitterisfixedtothepatient).Thenumberoftimesthispro-cessesisrepeateddependsontheacutenessofthediseaseprocess,fromhourlyapplicationsforacutecasestoonce-dailyapplicationsforchronicconditions.

Aroundoftherapyusuallyinvolvesdailyproceduresperformedfor5to10days.

Key indications for using EHF therapy:

• Initialpresentationofacuteviralrespiratoryinfections.• Painsyndromeatanylocation.• Jointandspineconditions.• Wounds,hematomas,burns.• Allergiesandskinconditions.• Cardiovasculardisease.• Diseaseofreproductionsystem.

EHF therapy should NOT be used in the following instances:

• Forpatientswithoutapositivediagnosis.• Forpatientswithindividualintolerancetothetherapy.• Forpregnantpatients.• For patients with implant devices with independent power supply, such as artificial

pacemakers.EHFtherapyhasamildsedativeeffectthatmaycausedrowsinessandreducedattention

inpatientswithheightenedsensitivitytoEHFradiation.Insuchcases,itisadvisabletoavoidperformingwork that requiresconcentration, includingdrivingavehicle, immediatelyaftertheprocedure.Forsafetypurposes,theproceduremaybecarriedoutbeforebedtime.

TheСЕМ®-ТЕСНapparatushasbeensuccessfullydemonstratedattradeshowsinRus-siaandaroundtheworld.Thedevicehasreceivedanumberofawards,including:GoldMedalatEWEI,Sofia,Bulgaria;SilverMedalatEureka,Brussels,Belgium,2001;SilverMedalatINPEX,Pittsburgh,PA,2001;GoldMedalatVDNKh,Moscow,Russia,2003.

You must to have the consultation of the doctor before the treatment.

These methods for using the СЕМ®-ТЕСН appa-ratus have been approved by the Russian Ministry of Health. The quality assurance system under which the apparatus is manufactured is certified for conformance to European Union standards.

4

NANOTECHNOLOGY IN MEDICINE

СЕМ®-ТЕСН Patents:

1. RF Patent of Invention 2281129 “Portable pulse apparatus for electrotherapy,”dateofpriorityOctober15,2004.

2. U.S.patent6122550“Devicefortherapeuticactiononhumanorganism,”dateofpri-oritySeptember19,2000.

3. CertificateofTrademark306040for“СЕМТЕСНСЕМТЕХ,”dateofpriorityFeb-ruary07,2005.

4. CertificateofTrademark351257for“СЕМТЕСНСЕМТЕХ,”dateofpriorityMay15,2006.

5. CertificateofTrademark348805for“СЕМТЕСНСЕМТЕХ,”dateofpriorityMarch20,2007.

6. CertificateofEuropeanTrademark989300for“СЕМТЕСНСЕМТЕХ”.7. CertificateofTrademark344494for“BRRTherapy,”dateofpriorityAugust10,2006.8. Internationalapplicationforpatentofinvention“Deviceforregulatingphysiological

processesinabiologicalobject”РСТ/RU2008/000282,Patent2341851.9. Usefulmodel“Connectingandfasteningmechanism,”Patent76786,dateofpriority

May07,2008.10.DesignApplication2008500403“Apparatusforphysicaltherapy”.11.InternationalTrademarkApplicationfor“СЕМТЕСНСЕМТЕХ”.12.ApplicationforPatent2008127927“Methodforincreasingresistivityofbiologicalob-

jects”.13. ApplicationforPatent2008138337“Methodofprotectionfromthenegativeeffectsof

radiationfromcellphoneandwirelessphone”.14. UsefulModelApplication2008138260“Wirelesstelephone”.

CJSC CEM Technology and LLC Spinor are performing the following joint research projects with support from the Foundation for Supporting Small Businesses in the Field of Science and Technology:

• START-2004“Designforanewmethodofpreventionandtreatmentofinfectiousdis-easesusingcontrolledenergymaterialtechnology”.

• START-2005“Designforanewmethodofrehabilitationforpsychologicalandemo-tionaldisordersandaportablephysiopunctureapparatus for individualusewith therehabilitationmethod”.

• START-2006“Designforanewmethodofpreventionandtreatmentofinfectiousandinflammatorydiseasesoforalorgansandtissues”.

• START-2008“Groupofdevicesforprotectingindustrialmaterialsfrommicrobiologi-caldamage”.

5

List of Studied Results of the Application of EHF and BRR Therapy:

Clinical Condition Result of EHF Therapy

Neurology

Cerebralatherosclerosis Normalized cerebral circulation and lipid exchangeindicators

Headache Significant reduction in pain intensity and durationofepisodes

Vertebrobasilarinsufficiency Eliminationorsignificantreductioninheadpainanddizziness

Neurologicalsymptomsofdegenera-tivespinedisease,includingdisksyn-drome

Significant pain reduction, increased pain thresholdinlocalalgogeniczones

Thermographicpictureofdegenerativediseaseofthecervicothoracicvertebrae

NormalizedthermographicpictureafterEHFtherapy

Pediatricscoliosis Significantpainreduction,increasedtoleranceofphy-sicalexertion,increasedamplitudeofspinemotion

Exogenic-organicbraindamage(ofatraumatic, vascular, infectious/toxicandcombinednature)

Eliminationofasthenicsymptoms,moodswings,hy-peresthesia,headaches,dizziness,arterialbloodpres-surefluctuations,nighttimesleeprestoration

Mono-andpolyneuropathy Painreduction,increasedspeedofnerveimpulsecon-duction

Vegetativedisorders, includingvege-tativecrises(panicattacks)

Normalizedvegetativecondition,reductionorelimi-nation of headaches, improved hemodynamics basedonrheography

6

Clinical Condition Result of EHF TherapyPost-traumaticandstressdisorders–treatmentandprevention

Reductionoreliminationof irritability,mood swingsandsleepdisorders;improvedmoodandworkcapacity

Infantilecerebralpalsy Reducedmuscletone,increasedmobilitylevel

Epilepsy,includingdrug-resistant Reductioninthenumberofseizuresandpositivedy-namicinEEGpicture

Pulmonology

Thermographicpictureofleft-sidepneumonia

NormalizedthermographicpictureafterEHFtherapy

Pneumonia Increasedeffectivenessoftreatment,reduceddurationoftreatment,preventionoflingeringillness

Chronicnonobstructivebronchitis Anti-inflammatoryeffect

Chronicobstructivebronchitis Reliefofbroncho-obstructivesyndrome

Sarcoidosisofthelungsandintratho-raciclymphnodes

Normalizedx-rayand immunogrampicture,norma-lizedrespiratoryfunction,reducedfrequencyofaggra-vationandrecurrence

Bronchialasthma Reduced coughing and shortness of breath, reducedneedforinhaledbronchialspasmolytic,improvedmu-cus discharge, normalized respiratory function, im-munomodulatoryeffect

Vascular DiseasesObliterativeatherosclerosisofthear-teriesofthelowerlimb

Eliminationofpainsyndrome,reductionofintermit-tentlameness

Obliterativeendarteritis Eliminationofpainsyndrome,reductionofintermit-tentlameness

Raynaud’sdisease Improvedperipheralcirculationandmicrocirculation

Post-thromboticsyndrome Elimination of pain syndrome, faster healing of tro-phiculcers

Miscarriage Increaseddurationofthelutealphaseofthemenstrualcycle, increased levels of estradiol and progesterone,eliminationoftheneedforhormonetherapy

7

Clinical Condition Result of EHF TherapyPostabortalcomplications Immunomodulatoryeffect,reductionofinflammatory

complications

Chronic inflammation of the fallo-piantubes,includingimpairedrepro-ductivefunction

Pain-relievingeffect,softeningofadhesivestructures,restoredreproductivefunction

Arthropathy

Degenerative and dystrophic ar-thropathy (deformative osteoarthri-tis,psoriaticosteoarthropathy)

Anti-inflammatory effect, increased muscle strength,range of motion in affected joint and tolerance ofphysicalexertion

Thermographicpictureofrightkneearthritis

ImprovedthermographicpicturewithEHFtherapy

Hemarthrosisandhemophilicjoints Pain-relievingeffect,normalizedhemostasis

Rheumatoidarthritis Significantreductionofpainandmorning jointstiff-ness,immunomodulatoryeffect

Surgical Pathology

8

Clinical Condition Result of EHF TherapyTraumatic and post-operative dam-age to skin, soft tissueandbone tis-sue, including complications due toinfectionandslowhealing

Shortening of all phases of the wound process, anti-inflammatory effect, promotion of regeneration,includingofbone tissue,preventionof infection, sig-nificantpain-relievingeffect,reduceddosagesofpain-relievingmedications

Burns Pain-relievingeffect,fastgenerationofgranulationtis-sueandepithelialization

Post-traumaticosteomyelitis Reduceddurationoftheexudativephaseofinflamma-tionandstimulationofregenerativeprocesses

Post-traumaticstiffness Pain-relieving effect, normalization of microcircula-tion and trophic disturbances, restoration of normalrangeofmotion

Acutecholeocystitis Anti-inflammatoryeffect

Acutepancreatitis Reduceddurationoftreatment,positiveeffectonim-munesystemcondition

Gastroenterology

Ulcerofthestomachandduodenum,including bleeding complications,perforationorpenetration

Reduceddurationofepithelializationofulcerarea,re-ducedfrequencyofrecurrence

Functionalincompetenceofbilepas-sages

Fasterandmoreeffectivereliefofpainanddyspepsia,reducedsymptomsofbileinspissationsandcrystalliza-tion,normalizedgallbladdercontraction

Chronic gastroduodenitis, includinginfectionbyHelicobacterpilori

Fasterandmoreeffectivereliefofpainanddyspepsia

Chronicpancreatitis Effectivepainrelief,restoredpancreasfunction

Dermatology

9

Clinical Condition Result of EHF TherapyPsoriasis Anti-inflammatoryandregenerativeeffect,resorption

ofinfiltration,reduceddurationoftreatment,reducedfrequencyofrecurrence

Trophiculcers Anti-inflammatory, analgesic and regenerative effect,reduceddurationoftreatment,fasterepithelializationofulcerarea

Atypicaldermatitis Anti-allergiceffect,eliminationofitching

Microbialeczema Fasterhealing

Acne Fasterhealing

Neurodermatitis Reducedskinitching

Vitiligo Restoredpigmentation

Herpes Significantanalgesicandanti-inflammatoryeffects

Syphilis Immunomodulatory effect, faster return of negativeserologicalresponses

Infectious and Parasitic Diseases

Chronicopisthorchiasis Improved gallbladder contraction, disappearanceofOpisthorchiseggsinbile

Tuberculosis of the lungs, includingwithChlamydiaormycoplasmal in-fections

Stabilization over the course of tuberculosis of thelungs,reducedfrequencyofpost-operativecomplica-tions,fasterresorptionofinfiltration,abacillationandclosingofdecaycavities

Tick-borne encephalitis and tick-borneborreliosis

Increasedmobility,reducedintensityofheadachesandarthralgia,normalizedsleep,reduceddurationoffeverandasthenia,increasedantibodytiter

Viralhepatitis Fasterhealing

10

Clinical Condition Result of EHF Therapy

Thermographicpictureofacuterhinitis

NormalizedthermographicpictureafterEHFtherapy

Acute respiratory viral infections —preventionandtreatment

Ratesofinfectioncutinhalf,mildersymptomsduringillness,reduceddurationofillness,absenceofcompli-cations

Cardiology

Coronary heart disease: exertationalangina, unstable angina, myocardialinfarction,arrythmia

Significantantianginaleffect,reducednumberofan-ginaattacks,episodesofpainlessmyocardialischemiaandarrythmia,improveddiastolicfunctionoftheleftventricle, reduced dosage of nitroglycerine, norma-lizedantithrombinIIIactivityanderythrocytedefor-mation

Arterial hypertension, including hy-pertoniccrises

Hypotensive effect, reduced peripheral resistance,improved cerebral circulation, normalized catechol-amineexcretion

Non-coronary myocardial damage(mitralvalveprolapse,cardiomyopa-thy,myocarditis)

Reduced frequency of cardialgia, normalized hemo-stasisindicators,improvedqualityoflife

Eye ConditionsDiabeticretinopathy Improved electro-oculogram indicators, elimination

ofunpleasantsensationsintheeye

Inflammatoryeyediseases Eliminationofitching,antiallergiceffect

11

Clinical Condition Result of EHF Therapy

Degenerative diseases of the retinaandopticnerve

Improved vision sharpness, improved field of vision,improvedmicrocirculation

Oral Medicine

Adentiaanduseofprosthodontics Significantanti-inflammatoryeffect

Gingivitis Significantanti-inflammatoryeffect

Periodontaldisease Significant anti-inflammatory effect, stimulated re-generation,normalizedlocalcirculationinperiodon-taldisease

Thermographicpictureofsubmaxillarylymphadenopathy

Improvedthermographicpic-turewithEHFtherapy

Submaxillarylymphnodeaftertoothextraction

Significantanti-inflammatoryeffect

Andrology

Andropausedisturbances Increasedsexdrive,improvedsexualfunction

Benignprostatichyperplasia Increasedsexdrive,improvedsexualfunction

Chronicprostatitis Reliefofpainanddysuricsymptoms,improvedsexualfunction

Secretoryandtoxicinfertility Stimulationofspermatogenesis

Endocrinology

Grave’sdisease Reducedsizeofthyroid,changeinitstexture

12

Clinical Condition Result of EHF Therapy

Nodulargoiter Eliminationorreductioninthesizeofsolitarynodes

Diabetes and its complications (mi-cro- and macroangiopathy, hepato-sis,cataracts,nephropathy)

Regression of complications, stabilization of diseasecourse,reducedneedforinsulin

Liver Disease

Cirrhosis Normalizedbiochemicalindicatorsandliversizeandstructure

Chronichepatitis Normalizedbiochemicalindicatorsandliversizeandstructure

Hepatosis Normalizedbiochemicalindicatorsandliversizeandstructure

Toxicliverdamage Normalizedbiochemicalindicatorsandliversizeandstructure

Chemical Dependency

Chronicalcoholism Reducedpsychologicalstrain,anxiety,desireforalco-hol

Substanceabuse Positiveeffectonpsychological,emotionalandsoma-ticaspects

Oncology

Malignant neoplasms (including co-lonandrectalcancer,skinmelanoma,stomach cancer, mammary tumors,lung cancer, ovarian cancer, canceroftheENTorgans)

Reduction of the number and degree of polychemo-therapycomplications, reducing the frequencyof re-currenceandmetastasis,pain-relievingeffect

Beningovariantumors Normalizationofsexhormonesecretionandimmunecondition

Uterinefibroids Reductionoffibroidsize

Lymphomas (lymphogranulomatosisandnon-Hodgkinlymphomas)

Activationofbody’santioxidantdefenses,suppressionof free radicaloxidationandnormalizationofproin-flammatorycytokinelevels

Benignmammarytumors Preventionofmalignantchange

13

NANOTECHNOLOGY IN MEDICINE*DatatakenfromguidelinesapprovedbytheRussianMinistryofHealthandclini-

calstudiesperformedandanalyzedduringtheprocessofcertifyingtheСЕМ®-ТЕСНapparatusincountriesoftheEuropeanUnion.Thestudiesdescribecompletedpro-spectivecontrolledstudiesofEHFtherapyforvariousconditionsperformedaccordingto the criteria of evidence based medicine. Control groups were given standard treatment.TreatmentoftheprimarygroupsofpatientsincludedEHFtherapy.

CompleteinformationonclinicalstudiescarriedoutusingtheСЕМ®-ТЕСНapparatuscanbefoundatwww.spinor.ru.

14

NANOTECHNOLOGY IN MEDICINE

EHF Therapy Offers the Following Solutions in Oncology:

1. Preparecancerpatientswiththemostcommonlocalizationsforthestagesofcom-binedtherapy(preparingorgansandsystemsforsurgicalintervention,radiationdam-ageandaggressivedrugregimens).

2. Treatassociatedconditionsandpreventcomplications.3. Preventandtreatcomplicationsfollowingspecializedtreatmentmethods.4. Treatparaneoplasticsyndrome.5. Improveresultsofothertreatmentmethods.6. Palliativecareforterminalpatients.7. Systemiccorrectionofenvironmentalandpre-cancerouspathology.8. Preventprogressofneoplasticprocessaftercombinedtherapy.

Proven Mechanisms of Action for EHF and BRR therapy:

• Normalizationoflipidexchange(reducedconcentrationofatherogenicfractionsandincreasedhigh-densitylipoproteincontent)(Kuz’menko,1998).

• Normalizationofthebalanceofcoagulantandanti-coagulantfactors(normalizationofantithrombinIIIlevels,fibrinolyticpotentialandthrombocytichemostasis)(Lopa-tinaN.A.etal.,2003;Bukatko,V.N.2003).

• Normalization of the balance of pro- and anti-oxidant systems (Tumanyants Ye. I.,TemuryantsN.A.,1997).

• Promotionofcellregeneration(enhancedproliferationoffibroblasts)(PolyakovaA.G.etal.,1999).

• Promotionofhemogenesisinredbonemarrow(LebedevaN.N.,KotrovskayaT.I.,2002).• Normalizationofbloodflowproperties(reductionofbloodviscosity,increasederyth-

rocyteelasticity)(ParshinaS.S.,etal.,2003).• Normalizationofimmunesystemfunctioning(normalizationofthenumberofТand

В-lymphocytesandA,GandMimmunoglobulins,normalizationofthefunctioningofneutrophils,restorationofthefunctioningofВ-lymphocytesandleukocytephago-cyticactivity)(Shliapaketal.,1996;Bakaliuketal.,1998;Kuz’menko,1998;JinZ.,LinM.,XiaJ.,ZhuangJ.,YangR.,LiX.,etal.,2001;BriskinB.C.andetal,2003;BukatkoB.N.,2003).

• Restoration of the ability of mononuclear phagocytes to secrete interferon gamma,whichcanreduceincidencesofcancerinriskgrouppatients(SitkoS.P.etal.,1993).

15

NANOTECHNOLOGY IN MEDICINE• Anti-inflammatory effect based partly on stimulation of the functioning

ofphagocytesandregulationofthedegranulationofmastcells(GapeyevA.B.,ChemerisN.K.,2007).

• Normalization of the secretion of catecholamines and sex hormones (Tsa-revА.А.,KudinovaМ.А.,1997;ZaporozhanV.N.etal.,1997).

• Impactontheendogenousopioidsystem(Radzievskyetal.,2001),activationofthean-tinociceptivesystem(KirovaB.V.,2000).

• Normalizationofbrainelectricalactivity(stabilizedalpha-rhythm,restorationofini-tially disrupted interzonal and interhemispheric relations of the key EEG rhythms)(Tyshkevichetal.,1998;GubarecM.Y.,1989;StolbikovA.E.andetal,1991).

• Normalizationofvegetativeregulation,stabilizationofthebalancebetweenthesympa-theticandparasympatheticbranchesofthevegetativenervoussystem(DikkeG.B.,1999).

• Antistressoractivity—inhibitionofexcessactivityinthesympathoadrenalsystemandactivationofthestress-limitingsystems(ChuyanYe.N.,TemuryantsN.А.,2005).

• Inhibitionoffluvirusreplicationincells,anti-viraleffect(PodchernyaevaR.Ya.etal.,2004).

• Cytoprotectiveeffectonredbonemarrowandliverinpatientsreceivingpolychemo-therapy(KarevaN.P.etal.,2006).

• Changetothestructuralanddynamiccharacteristicsofcellmembranes(SeminaI.G.etal.,2007).

• Slowingofagingprocessesforskin,liverandthecentralnervoussystem(RodshtatI.V.,2007).

• Normalization of vascular tone and promotion of microcirculation, normalizationoftheresponsivenessofvascularendothelium(normalizedrheogramandrheoenceph-alogramindicators)(ParshinaS.S.etal.,2003;DikkeG.B.,1999;AfanasyevaТ.N.,PetrovaV.D.,1995;TsarevА.А.,KudinovaМ.А.,1997).

• Increased overall resistance (immunity) to many different negative factors (Tuman-yantsYe.I.,TemuryantsN.А.,1997).

Thermographicpictureofsecondarythymic-dependent

immunodeficiency

NormalizedthermographicpictureafterEHFtherapy

16

NANOTECHNOLOGY IN MEDICINE

Notes